PRO 2000 blocker of gp120 binding to CD4: Began Phase I/II dose escalation trial of safety and antiviral activity in the Netherlands

Procept Inc. (PRCT), Cambridge, Mass. Product: PRO 2000 blocker of gp120 binding to CD4 Indication: HIV infection Status: Began Phase I/II dose escalation trial of safety and antiviral activity in th...